Recent studies have identified factors responsible for angiogenesis within developing tumors, but mediators of vessel formation at sites of trauma, injury, and wound healing are not clearly established. Here we show that sphingosine 1-phosphate (S1P) released by platelets during blood clotting is a potent, specific, and selective endothelial cell chemoattractant that accounts for most of the strong endothelial cell chemotactic activity of blood serum, an activity that is markedly diminished in plasma. Preincubation of endothelial cells with pertussis toxin inhibited this effect of S1P, demonstrating the involvement of a G ␣i -coupled receptor. After S1P-induced migration, endothelial cells proliferated avidly and differentiated forming multicellular structures suggestive of early blood vessel formation. S1P was strikingly effective in enhancing the ability of fibroblast growth factor to induce angiogenesis in the avascular mouse cornea. Our results show that blood coagulation initiates endothelial cell angiogenic responses through the release of S1P, a potent endothelial cell chemoattractant that exerts its effects by activating a receptor-dependent pro-
The directed, chemotactic migration of endothelial cells is a critical component of angiogenesis, the process by which new capillaries are formed from existing blood vessels (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . A complete understanding of endothelial cell chemotaxis and the factors that induce it are essential for a thorough understanding of the basic mechanisms of angiogenesis as well as for the development of methods designed to regulate the response. Several proteins that mediate endothelial cell chemotaxis, including vascular endothelial growth factor (VEGF) and fibroblast growth (FGF) factor, have been identified (11, 12) . These proteins are thought to play a key role in the vascularization and resultant survival of growing tumors since neutralizing antibodies effect a marked decrease in cancer progression as a result of inhibition of blood vessel formation (6, 13) . Furthermore, inhibition of angiogenesis and tumor survival has been observed by antagonizing the specific receptors for these endothelial cell chemoattractants (7, 8) . Consequently, there is tremendous interest in the possibility of manipulating the angiogenic response in growing tumors for therapeutic purposes, and several candidate pharmacological agents, including angiostatin, thrombospondin and endostatin, have been identified (1) (2) (3) .
Much less is known about mediators of the angiogenic response in injured and traumatized tissue, a response necessary for normal wound repair. While fluids extracted from human surgical wounds possess potent angiogenic factors, the response they induce is not consistently inhibited by neutralizing antibodies to known angiogenic proteins (9) . In addition, the physiological role of biologically active lipids, including those released by activated platelets (14 -18) , in inducing angiogenic responses of endothelial cells has not been assessed. Moreover, the factors in blood serum that are responsible for its ability to attract endothelial cells have not been identified. We therefore directly examined the hypothesis that factors released into serum during blood clotting play an important role in neovascularization by inducing endothelial cell migration and subsequent angiogenic differentiation. The results implicate platelet-derived sphingosine 1-phosphate (S1P) as a novel angiogenic modulator that accounts for the ability of blood serum to attract endothelial cells and promote angiogenic differentiation.
MATERIALS AND METHODS

Reagents
Chemicals, reagents and lipids were obtained from Sigma Chemical Co. (St. Louis, Mo.), unless noted otherwise. Human blood was obtained from healthy donors of both sexes and anticoagulated with 0.1 volume of acid citrate dextrose solution A (Sigma). Bovine pulmonary artery endothelial cells (BPAEC) and human umbilical vein endothelial cells (HUVEC) were obtained from Cell Systems Corp. (Kirkland, Wash.) after their third passage and propagated in Dulbecco's minimal essential medium containing endothelial growth supplement and nonessential amino acids. Neutrophilic leukocytes were prepared from heparinized human blood (19) . Rat-2 fibroblasts and human embryonic kidney epithelial cells (HEK-293) were obtained from the American Tissue Culture Collection (ATCC, Manassas, Va.). Transwell chemotaxis chambers (6.5 mm diameter, 8 m pore size) were obtained from Costar, Inc. (Cambridge, Mass.); Blind Well chemotaxis chambers and 8 m pore size filters were obtained from Neuroprobe, Inc. (Cabin John, Md.). Lipids were dissolved in ethanol at 1 mM. Lyophilized pertussis toxin (List Biochemicals, Campbell, Calif.) was dissolved in water at 500 g/ml. Fetal bovine serum was from Hyclone, Inc. (Logan, Utah). Charcoal-stripped fetal bovine serum (FBS-C) was prepared by incubating 100 ml FBS with 1.5 g of washed, activated charcoal (Sigma) for 24 h at 4°C to remove S1P and other lipid growth factors (20) . After incubation, charcoal was removed by centrifugation and ultrafiltration. Chemotaxis filters were treated with 0.2 g rat tail collagen (Boehringer Mannheim, Indianapolis, Ind.) and dried overnight, unless indicated otherwise. Tissue culture media and growth supplements were obtained from Life Technologies, Inc. (Grand Island, N.Y.). Bovine plasma fibronectin was obtained from Sigma and dissolved in saline at a concentration of 1 mg/ml. Growth factor-reduced Matrigel was from Collaborative Biomedical Products (Bedford, Mass.).
Migration assays
For most experiments, BPAECs between passages 5 and 15 were dislodged after brief trypsinization and dispersed into homogeneous cell suspensions, which were washed extensively and resuspended in DMEM at a concentration of 10 6 cells/ml. To assess migration from established monolayers, cells (10 5 ) were dispersed onto collagen-coated chemotaxis filters within Transwell inserts and allowed to adhere for 30 min at 37°C, when they were challenged by adding 300 l of a chemoattractant solution to the lower compartments. Where indicated, chemotaxis was monitored using Blind Well chemotaxis chambers and 8 m collagen-coated pore-size filters. In the experiments shown, the chemotactic activity of lipids, cell extracts and thin-layer chromatography (TLC) fractions was assayed after reconstitution of indicated amounts into medium containing 5% FBS-C, which itself possessed little chemotactic activity (see below). Unless otherwise indicated, migration was allowed to proceed for 2 h at 37°C. Cells remaining attached to the upper surface of the filters were carefully removed with a cotton swab; cells that had migrated to the lower surface were fixed with formaldehyde, stained with hematoxylin, and enumerated by microscopic examination. The average number of migrating cells/ field was assessed by counting at least 4 random fields/filter at 200ϫ magnification. Data points indicate the mean (Ϯ sd) obtained from three separate chambers within one representative experiment that was repeated at least twice. Although the relative activity of different samples was consistent among experiments, the magnitude of optimal responses expressed as the average number of cells/field varied.
Where indicated, HUVEC, human neutrophils, rat-2 fibroblasts or human embryonic kidney epithelial cells were tested for chemotaxis using methods similar to those described above. HUVECs, fibroblasts and epithelial cells grown on monolayers were dislodged by trypsinization and seeded onto 8 m collagen-coated filters prior to chemotactic challenge. After 2 h incubation, filters were removed and stained as described above, and migration was compared to that observed with BPAEC. Neutrophils were suspended in Hanks' balanced salt solution at a concentration of 2 ϫ 10 7 cells/ml prior to addition to 5 m Transwell inserts and immediately placed above lower chambers. After incubation for 1 h at 37°C, cells in lower compartments were recovered and enumerated.
In some experiments, migrating cells fixed to the lower surface of filters were permeabilized and stained with FITCconjugated NBD phalloidin to visualize F-actin. Cells were fixed by immersing the filters in 5% formaldehyde at room temperature. After 15 min, cells were permeabilized by adding 1 mg/ml egg yolk L-lysophosphatidylcholine (Sigma). Permeabilized cells were incubated for 20 -30 min with 500 nM NBD-phalloidin (Molecular Probes, Eugene, Oreg.) delivered from a freshly prepared 6.6 M stock solution in methanol in the dark at room temperature. Filters were then rinsed in absolute ethanol, mounted under immersion oil and examined at 1000ϫ magnification. Photomicrographs were obtained using an Olympus BM-2 fluorescent microscope equipped with a PM-BV3 photomicroscopy system.
In vivo assessment of angiogenesis
Angiogenic responses in the avascular cornea of 7-9 wk old C57/B16 mice induced by indicated factors embedded in hydron pellets in the presence of sodium sucralfate were assessed as described (21, 22) . Corneal micropockets were created in both eyes of anesthetized animals with a modified von Graefe cataract knife. Pellets of ϳ0.4 ϫ 0.4 ϫ 0.2 mm coated with type NCC hydron polymer (Interferon Sciences, New Brunswick, N.J.) containing indicated amounts of test substances or vehicle were implanted ϳ1.2 mm from the vascularized limbus. Erythromycin ointment was then applied to each eye and responses were recorded 5 days after insertion of hydron pellets into corneal micropockets by slit lamp photography. All substances were tested in three separate experiments.
Endothelial cell morphogenesis on Matrigel
The differentiation of HUVECs into capillary-like networks was examined using Matrigel supports, as described (23) . After trypsinization and washing, 2.5 ϫ 10 4 cells in 200 l RPMI 1640 were plated onto 200 l of growth factor reduced Matrigel (12.4 mg protein/ml) in the presence and absence of 2% FBS-C and 100 M S1P at 37°C in 24-well plastic plates. Sixteen to 24 h later, cultures were examined microscopically for evidence of tube formation and photographed (40ϫ). The extent of formation of capillary-like structures was quantified by analysis of digitized images to determine the relative area covered by the tube-like network, using a commercially available image analysis program (Un-scan-it, Silk Software). Each sample was assayed in triplicate and experiments were repeated twice.
Serum growth factor levels
Human serum obtained from clotted blood of healthy individuals was assayed for the presence of various polypeptide growth factors including VEGF, hepatocyte growth factor (HGF), basic FGF (FGF-b), and platelet-derived growth factor AB (PDGF) using Quantikine immunoassay kits from R&D Systems (Minneapolis, Minn.). Levels of each growth factor were determined in serial dilutions of sera incubated overnight at 4°C in the presence and absence of activated charcoal (15 mg/ml). Each sample was spiked with 100 ng/ml FGF-b prior to assay since, unlike other factors tested, FGF-b was undetectable in fresh serum samples.
S1P release
Platelet-rich plasma (PRP) was prepared by centrifuging anticoagulated human blood at 200 ϫ g for 20 min at 20°C The resulting straw-colored supernatants were devoid of erythrocytes and leukocytes but contained platelets in numbers similar to those found in unseparated blood (200,000 -300,000/l). Platelet-poor plasma (PPP) was prepared by centrifuging PRP at 1250 ϫ g for 5 min. PPP and PRP were clotted in glass tubes by adding 10 mM CaCl 2 . After clot retraction at 37°C, samples were centrifuged at 1250 ϫ g and supernatants were harvested for analysis.
Lipid extraction and chromatography
Lipids were extracted from clotted human plasma with 2 volumes of 1-butanol in the presence of 0.01 M HCl. Extraction efficiency, determined with 32 P-S1P, was over 80%. Dried extracts were resuspended in ethanol at 1/30th the volume of the sample extracted. Solubilized extracts were assayed for chemotactic activity or further processed by TLC. Lipids spotted on 20 ϫ 20 cm silica gel G plates were initially separated using a solvent system consisting of chloroform: methanol:20% methylamine (36:60:10, v/v/v). Plates were sectioned to obtain lipids covering the entire area of migration and resolved lipids were eluted with chloroform:methanol:water (10:10:2, v/v/v). To effect better separation of PA, LPA and S1P, a two-phase system based on a method described previously (24) was used. Extracts spotted in the center of a plastic-backed TLC plate were chromatographed twice in the first direction using chloroform/methanol/ NH 4 OH (65:35:7.5, v/v/v), resulting in the separation of PA, LPA, and S1P from other detectable lipids. After cutting the plates above the origin to remove other lipids, phosphatidate, lysophosphatidate, and S1P that remained at the origin were chromatographed three times in the opposite direction with chloroform/methanol/acetic acid (8:2:1, v/v/v). This effected clear separation of phosphatidate, lysophosphatidate, and S1P standards, which were visualized with molybdenum blue. Areas of the plates corresponding to the migration position of these standards were excised and lipids were eluted as described above. Eluates were dried and resuspended in ethanol for analysis of chemotactic activity or confirmatory chromatographic analyses, as described below.
Statistical analyses
Data are presented as means Ϯ standard deviation. Statistical comparison between groups of data were carried out using the Student's t test.
RESULTS
Endothelial cell chemoattractive activity of human serum and plasma Figure 1a illustrates the release by platelets of a potent endothelial cell chemoattractant during blood clotting. Supernatants of human plasma clotted by recalcification in the presence of platelets induced vigorous endothelial cell migration, even when diluted 100-fold. Plasma clotted in the absence of platelets exhibited significantly less activity. Optimal levels of migration were induced when concentrations of activated plasma of ϳ5% were used in lower compartments of chemotaxis chambers. Heating at 60°C for 30 min did not significantly decrease the endothelial cell chemoattractive activity of supernatants of clotted platelet-rich plasma (Fig. 1b) . The majority of this activity was lost, however, when samples were treated with activated charcoal, a procedure known to remove lipid growth factors, including LPA and S1P (20) . FBS also possessed strong endothelial cell chemotactic activity; this activity was completely depleted by treating the serum with activated charcoal (Fig. 1b) .
Butanol extracts of chemotactically active plasma were examined for their ability to restore chemotactic activity to FBS-C, since butanol extraction, like charcoal treatment, effectively removes biologically active lipid factors from tissues and fluids (20) . When butanol extracts of active plasma were reconstituted into FBS-C, the resultant mixtures were strongly chemotactic (Fig. 1c) . As little as 0.1 l of butanol extract (equivalent to 3 l of clotted plateletrich plasma) promoted migration when introduced into chemoattractant compartments with a final volume of 300 l (Fig. 1d) . A butanol extract of clotted platelet-poor plasma prepared in parallel was far less active. In the experiment shown, activity observed with 0.5 l of the active extract was similar to that obtained with a 5% solution of active plasma prior to extraction. The chemotactic activity of the butanol extracts was therefore ϳ30-fold stronger than that of the original extracted plasma. Since extracts were concentrated 30-fold compared to their original volume, activity within butanol extracts accounted for most, if not all, of the activity released by platelets during clotting.
Thin-layer chromatographic analysis of the plateletderived endothelial chemoattractant
We purified the endothelial cell attractant from active butanol extracts by 1-dimensional TLC. Over 80% of the reconstituted chemoattractant activity was recovered from the area of silica gel that corresponded to the position of an S1P standard (Fig. 2a) . Low levels of activity were recovered in fractions corresponding to the elution position of phosphatidate, but other fractions covering the entire range of the resolved plate were devoid of activity. Markedly less activity was recovered from corresponding fractions after chromatography of extracts of supernatants of clotted platelet-poor plasma. Since lysophosphatidate was not clearly separated from S1P by the solvent system used, we resolved butanol extracts with a two-phase system designed to separate more effectively phosphatidate, lysophosphatidate, and S1P while removing other lipids. This approach demonstrated that more than 95% of the endothelial cell attractant factor extracted from plasma clotted in the presence of platelets comigrated with S1P (Fig. 2b) . This activity was clearly resolved from both lysophosphatidate and phosphatidate. To confirm further the identity of the resolved entity as S1P, we rechromatographed the active material recovered from the two-phase solvent system with two additional solvent systems with different resolving properties as described in Fig. 2 . In both cases, activity was recovered only in fractions at the migration position of the S1P standard (Fig. 2c) . Thus, we established by chromatography in four different solvent systems that S1P is the predominant endothelial cell attractant released from platelets during blood clotting.
Chemoattractive activity of other serum lipids
We examined the endothelial cell chemotactic activity of lipids that may be present in serum or released by platelets in order to validate the conclusions reached above. Nanomolar concentrations of synthetic S1P potently stimulated endothelial cell chemotaxis (Fig.  3a) ; concentrations of synthetic S1P as low as 12.5 nM induced a vigorous response. The chemotactic effect of S1P was not due to a contaminant in the synthetic S1P preparation used, since S1P recovered after thin-layer chromatography of the synthetic standard was similarly active (not shown). Of several nonphosphorylated lipids that may be present in serum, only anadamide (arachidonylethanolamide) possessed substantial activity (Fig. 3b) ; sphingosine, 12-hydroxyeicosatetranoic acid (HETE), 15-HETE, sphingomyelin, ceramide, and ceramide-1-phosphate were inactive when tested between 0.5 and 50 M (Fig. 3b) . Certain lysophospho- Figure 1 . Generation of endothelial cell chemotactic activity by platelets during clotting. a) Citrated plasma was clotted by recalcification in the presence or absence of platelets and assayed at the indicated dilutions for activity after removal of cells and fibrin by centrifugation. Responses of BPAECs are shown. Data points are given as means (Ϯ sd) of three determinations from a representative experiment that was repeated twice. The differences between all values obtained with plasma clotted in the presence vs. the absence of platelets were significant at PϽ0.001, as determined by the Student's t test. b) Human plasma (5%) clotted in the presence of platelets was tested for endothelial cell chemotactic activity either without further treatment (activated plasma), after heating to 60°C for 30 min or after treatment with activated charcoal. Results are compared to those obtained with a 5% solution of freshly thawed fetal bovine serum (FBS) or charcoal-treated FBS (FBS-C). For charcoal treatment, serum was incubated with activated charcoal (15 mg/ml) for 24 h, after which the charcoal was removed by centrifugation and ultrafiltration. The asterisks indicate statistical significance determined by the Student's t test (PϽ0.001) compared with activated plasma or untreated serum. c) Chemotactic activity of a butanol extract of clotted platelet-rich plasma (PRP). Butanol extracts were concentrated 30-fold compared to the volume of plasma extracted; in this experiment 0.5 l of the extracts were tested for activity after reconstitution into 5% FBS-C. Plasma from which the extracts were obtained (clotted PRP) was tested at a concentration of 5% in a final volume of 300 l. Astericks indicate statistical significance as determined by Student's t test (PϽ0.01) as compared to samples with no extract. d) Dose dependency of chemotaxis induced by extracts from plasma clotted in the presence (E) and absence (F) of platelets. Indicated amounts of each extract were assayed for endothelial cell chemotactic activity in the presence of 5% FBS-C in a final volume of 300 l.
lipids, including lysophosphatidylinositol and lysophosphatidylethanolamine, exhibited slight activity at low concentrations (1 M), but lysophosphatidate was completely inactive at 1 M (not shown) and exhibited very low activity when tested at higher levels. Phosphatidate and platelet-activating factor possessed weak activity at relatively high levels. Sphingosylphosphorylcholine, a lipid that induces responses similar to those induced by S1P when used at higher concentrations (25) , was also an effective endothelial cell chemoattractant, exerting effects 65-70% as well as S1P (500 nM) when tested at an optimal concentration of 10 M (data not shown).
Effect of charcoal stripping on protein growth factor levels in serum
Experiments were undertaken to confirm that the sharp reduction in the endothelial cell chemoattractive activity observed upon treatment of serum with activated charcoal did not result from adsorption and removal of protein growth factors. As shown in Table 1 , overnight treatment with activated charcoal had little effect on levels of VEGF, FGF-b, PDGF-AB, and HGF in human serum as determined by immunoassay. In addition, overnight treatment with charcoal had little influence on the chemotactic activity of solutions of VEGF, FGF-b, and HGF under conditions where the treatment markedly diminished the chemotactic potential of solutions of both S1P and dilute serum (PDGF solutions were found not to possess detectable endothelial cell chemotactic activity and were thus excluded from this analysis). In contrast, whereas heating overnight at 60°C had only a moderate inhibitory effect on the chemotactic potential of either isolated S1P or dilute human serum, overnight heating almost completely inhibited the chemotactic activity of solutions of VEGF, FGF-b, and HGF. These results are consistent with our conclusion that the endothelial cell chemotactic activity of human serum is due to its content of S1P and not a result of protein growth factors that may be released from platelets during blood clotting.
Kinetics, characteristics, and specificity of the endothelial cell response to S1P Figure 4a illustrates the dynamics of the vigorous endothelial cell response to S1P. Endothelial cells migrated rapidly from an established monolayer through collagen in response to 500 nM S1P reconstituted into FBS-C. Within 5 h, responding cells formed an almost confluent monolayer on the chemoattractant side of the micropore filters as actin stress fibers developed and converged into a contiguous net (Fig. 4b) . The responding cells then began to form multicellular structures that were well developed by 20 h incubation (Fig. 4a) , suggestive of early angiogenic differentiation. Consistent with this conclusion, S1P was found to effectively confer on FBS-C the ability to vigorously promote endothelial cell morphogenesis into capillary-like structures on Matrigel supports (Fig. 4c) , an assay widely used to define mechanisms and mediators of angiogenic responses. S1P alone was effective in inducing endothelial cell migration, but the response was markedly weaker than that observed when S1P was assayed in the presence of FBS-C (Fig. 4a) , as noted above for assays of activity within butanol extracts of serum (Fig. 1c) . This difference was ascribed to factors that enhanced endothelial cell interactions with the substratum, since the requirement for serum cofactors for optimal migration was lost when assays were carried out using filters coated with bovine plasma fibronectin (2 g) instead of collagen or by allowing endothelial cells to firmly adhere to and interact with the substratum for 2 h or longer before chemotactic challenge (data not shown).
The response to S1P in the presence of FBS-C was strongly attenuated when either S1P or whole FBS a Growth factors (FGF-b, VEGF, HGF, PDGF) dissolved in 0.4% fatty acid-free albumin in saline at a concentration of 100 ng/ml, human serum (HS, 2.5% in saline), and S1P (500 nM) were exposed overnight to activated charcoal (15 mg/ml) at 4°C or heat (60°C) and assayed for endothelial cell chemotactic activity. Results (meanϮsd, nϭ3) are compared to those obtained using solutions kept overnight at 4°C without charcoal.
b Sera obtained from 3 healthy individuals were spiked with 100 ng/ml FGF-basic and incubated overnight at 4°C in the presence and absence of 15 mg/ml activated charcoal. Results show recovery of individual growth factors as determined by ELISA % (meanϮsd).
c Not determined.
was included in both the lower and the upper compartments of chemotaxis chambers, thereby preventing the formation of a gradient of chemoattractant across the chemotaxis filters (Fig. 5a) . Charcoaltreated FBS, however, did not attenuate responses when added to upper compartments. In addition, S1P did not induce migration when added to upper compartments of chambers with FBS-C in the lower compartments. Finally, addition of both S1P and FBS-C to upper compartments did not induce migration when no additional factors were present in lower compartments. These experiments demonstrate that a gradient of S1P is required for optimal induction of endothelial cell migration and that S1P, but not its serum cofactor, desensitizes the response. Thus, S1P possesses properties of a true chemoattractant and induces directed, chemotactic endothelial cell migration. In the panels on the left, migration was induced by 500 nM S1P in the presence of 5% FCS-C for indicated times; in panels to the right, migration to indicated stimuli was allowed to proceed for 20 h. After migration, cells were fixed, stained with hematoxylin, and photographed at 100ϫ magnification (left panels) or 200ϫ (right). In response to S1P in the presence of FBS-C (counterclockwise from upper right), responding cells were evident within 1 h, forming a confluent monolayer within 5 h. By 11 h, cells that had migrated began to form multicellular structures suggestive of early blood vessel formation. By 20 h, these structures were well developed, prominently displaying their 3-dimensional characteristics (bottom, right). b) F-actin formation by cells migrating through filter pores in response to 500 nM S1P in the presence of 5% FBS-C. Panel 1 shows a cell as it first emerges through a micropore filter. Here actin strands are barely evident, perhaps pulling the anterior of the anchored cell into its new domain. 2) A cell bursts through a micropore as the developing actin net spreads across the substratum. 3) Stress fiber development is evident as emerging cells seek contact with one another. 4) Actin fibers in migrating cells form an intricate net, an early event in establishing a contiguous barrier in the developing monolayer. c) Promotion by S1P of endothelial cell differentiation on Matrigel supports in the presence of FBS-C. Images shown are representative of three within one experiment that was repeated twice. Tube formation in the presence and absence of 100 nM S1P and 2% FBS-C was quantified by image analysis to determine the area in each scan covered by the developing network. The results, expressed as the mean pixel density (Ϯ sd)/image of the 3 images obtained in this experiment, are noted within each respective box. Values obtained with and without S1P in the absence of FBS-C were not statistically different (PϾ0.25). FBS-C induced a statistically significant response in the absence of S1P (PϽ0.05). In the presence of FBS-C, the response in the presence of S1P was statistically greater than that observed in its absence (PϽ0.01). Responses observed in the presence of both S1P and FBS-C were similar to those observed in the presence of 2% untreated FBS in the absence of added S1P (not shown).
Experiments were performed to assess the specificity of the chemotactic response induced by S1P for endothelial cells, species specificity of the response, and the sensitivity of the response to pertussis toxin. Preincubation of endothelial cells with pertussis toxin (300 ng/ml) for 3 h at 37°C almost completely inhibited chemotaxis to S1P, consistent with the involvement of a Gi-linked receptor (Fig. 5b) . HUVECs responded to S1P as vigorously as BPAECs (Fig. 5b) . Of several cell types tested, including human neutrophils, rat-2 fibroblasts, and human embryonic kidney epithelial cells, only endothelial cells migrated in response to S1P (Fig. 5b) . Thus, S1P is a potent and specific chemoattractant that induces migration of human as well as bovine endothelial cells by activating a pertussis toxin-sensitive cellular process.
Angiogenic activity of S1P in vivo
Experiments were undertaken to assess the angiogenic activity of S1P in the mouse cornea micropocket assay, a well-established assay for assessing the angiogenic potential of various factors in vivo (21, 22) . As shown in Fig. 6 , S1P alone induced little vessel formation in the avascular mouse cornea. Responses to 10 nmol S1P were similar to those observed with vehicle (BSA) in the absence of angiogenic factors. FGF-b consistently induced an angiogenic response and this response was markedly potentiated by the addition of S1P. Thus, S1P is a potent endothelial cell stimulus that possesses the ability to promote angiogenic responses to protein growth factors in vivo. Figure 5 . Characteristics of endothelial migratory responses to S1P. a) Disruption of migration to S1P by alteration of the chemotactic gradient. In these experiments, chemotaxis was measured in Blind Well chemotaxis chambers to retard diffusion of chemoattractants between chamber compartments. Asterisks denote statistical significance as compared to responses of cells to chemoattractant (S1P ϩ FBS-C) in lower compartments only. Responses to S1P (500 nM) in the presence of 5% FBS-C were significantly inhibited by inclusion of whole FBS (5%) and 500 nM S1P alone, but not by 5% FBS-C. In addition, migration was not induced when S1P was added to upper, but not lower, compartments, indicating a concentration gradient of S1P from upper to lower compartments was necessary for optimal responses. b) Pertussis toxin sensitivity, species specificity and cell type specificity of chemotactic responses to S1P. In each case, responses were evaluated in comparison to those obtained with BPAEC. . Angiogenic responses to S1P in the avascular mouse cornea. Sucralfate supplanted Hydron pellets containing ϳ4 g BSA in the presence or absence of FGF-b (ϳ50 ng) and/or S1P (10 nmol) were implanted into micropockets within avascular corneas of C57/B16 mice, and blood vessel formation was assessed 5 days later by slit lamp photomicroscopy (21, 22) . In the two experiments shown, S1P induced a very weak angiogenic response but markedly enhanced responses induced by FGF-b, as evident from the photographic analysis. The results are representative of those obtained from three experiments, each carried out in duplicate.
DISCUSSION
The experiments in this report demonstrate that abundant endothelial cell chemotactic activity appears in serum during blood clotting. Based on this observation, our subsequent experiments focused on identifying the source and clarifying the nature of this activity. We traced the source of this activity to stimulated platelets. Although many growth factors in serum are released from activated platelets, the endothelial cell chemotactic activity of serum was found to be remarkably heat stable and readily extracted with either butanol or activated charcoal. In contrast, several protein growth factors potentially released by platelets into serum, including VEGF, FGF-b, HGF, and PDGF, were not extracted by activated charcoal. Furthermore, the chemotactic activity of solutions of protein growth factors was almost completely inhibited by prolonged heating whereas the activity of serum was not (Table 1) . Activity within butanol extracts of human serum was recovered after TLC developed with four different solvent systems in fractions that contained S1P but not LPA, PA, or other lipids. This activity accounted for virtually all of the activity present in the original extract. These results strongly indicated that the major chemoattractant for endothelial cells produced during blood clotting-and, indeed, the major endothelial cell chemoattractant in serum-is platelet-derived S1P.
To confirm the conclusion reached above, we tested the action of synthetic S1P in our system. Purified, synthetic S1P was found to be a potent endothelial cell chemoattractant. The chemotactic activity of purified S1P, like that of dilute serum, was heat stable and readily extracted with activated charcoal. In addition, of several lipids that may be present in serum, including LPA, PA, and plateletactivating factor, we found that none possessed the endothelial cell chemotactic activity that was observed with nanomolar concentrations of S1P. The results of this report thereby reveal that S1P is the major endothelial cell chemoattractant released into serum by platelets during blood clotting. Its activity accounts for almost all of the very potent endothelial cell chemotactic activity of FBS and a large portion of the substantial activity within human serum. Though previous reports have traced other biological activities of serum to the presence of LPA (14, 26), we believe this study is the first to directly trace a biological activity generated in serum or other tissue fluid to platelet-released S1P. The veracity of the response and its cellular specificity indicate that endothelial cell migration is an important, physiologically relevant consequence of S1P release from platelets. The mechanisms responsible for coagulation-initiated S1P release have not been explored in detail, but we have not been able to attain similar levels of release by stimulating washed platelets with thrombin, ADP, Ca 2ϩ ionophore, or other agonists in the absence of clotting (not shown). Thus, clotting is an extremely effective trigger of platelet S1P release and may thereby play an important role in initiating angiogenesis.
Whereas platelet-released S1P may play an important role in the angiogenic response by attracting endothelial cells to the sites of injury and trauma, the lipid may exert additional effects in angiogenic differentiation of the cells after chemotactic migration. We demonstrated that cells that responded chemotactically to S1P began to differentiate into multicellular structures, suggestive of new blood vessel formation. These results must be carefully interpreted because optimal responses were observed in the presence, but not the absence, of FBS-C. Thus, it appears that that serum cofactors play an important role along with S1P in inducing optimal angiogenic responses. Consistent with this conclusion, S1P effectively restored to charcoal-treated FBS the ability to promote endothelial cell morphogenesis into capillary-like structures on Matrigel basement membrane supports. Whereas S1P and FBS-C alone promoted morphogenesis in this assay system, the two agents added together induced an optimal response, consistent with our conclusion that serum cofactors accentuate angiogenic responses to S1P. In vivo, S1P only weakly induced angiogenesis in the avascular mouse cornea, but markedly enhanced responses to FGF-b. It therefore appears likely that S1P is an angiogenic cofactor that exerts optimal effects in conjunction with protein or other lipid growth factors generated in serum and other biological fluids.
Our conclusion that S1P produced during blood clotting acts as an endothelial cell attractant and angiogenic factor is supported by recent results demonstrating the induction of endothelial cell angiogenic responses by purified S1P (27) (28) (29) . S1P appears to induce these responses through activation of members of the EDG (endothelial differentiation gene) family of receptors. The prototype of this G-protein-coupled receptor family, EDG-1, was found to be induced in endothelial cells during an in vitro model of angiogenesis several years ago (30) . The subsequent demonstration that the EDG-1 receptor binds S1P with high affinity (20, 31) led to the hypothesis that S1P plays an important role in angiogenesis (20) , but its mechanism of action is only recently beginning to emerge. In this respect, Wang et al. recently demonstrated that overexpression of EDG-1 by nonresponsive cells confers on them chemotactic responsiveness to S1P (27) . Endothelial cells that expressed EDG-1 proliferated in response to S1P. Both human and bovine endothelial cells that expressed EDG-1 migrated chemotactically to S1P, as shown by checkerboard analysis, and this response was blocked by pretreatment of cells with pertussis toxin, consistent with an involvement of EDG-1. Consistent with this conclusion, a recent report from our group demonstrated that migration of endothelial cells to S1P was almost completely inhibited when the cells were preincubated with antisense oligonucleotides formulated to blunt expression of EDG-1 (29) . In another recent study, antisense oligonucleotides formulated to inhibit expression of both EDG-1 and EDG-3, a homologue of EDG-1 that also binds S1P with high affinity, attenuated the ability of S1P to induce VE-cadherin localization at endothelial cell adherens junctions, an early event in angiogenic differentiation (28) . Whereas antisense to EDG-1 prevented the formation of cortical actin structures in S1P-stimulated HUVECs-a process dependent on activation of the Rac pathway-the formation of stress fibers (a Rho-dependent process) was specifically inhibited by antisense to EDG-3. Antisense to EDG-1 and EDG-3 inhibited endothelial cell morphogenic differentiation induced by S1P in an additive manner, indicating that this process results from activation cascades evoked by more than one cellular pathway. Finally, similar to the results of our study, S1P was found to possess the ability to potentiate angiogenic responses induced by polypeptide growth factors in vivo, as assessed using the mouse Matrigel assay. The authors concluded that endogenous production of S1P may be an important aspect of the angiogenic response. Our results add an important extension to this work and demonstrate a novel link between blood clotting-or hemostasisand endothelial cell angiogenic responses.
Although the critical role of angiogenesis in tissue repair after lacerations, abrasions, and traumatic injury appears obvious, the essential mediators of the response have not been identified. The present work demonstrates a direct link between an early yet key component of angiogenesis, directed endothelial cell migration, and blood coagulation. This link is mediated by S1P released from platelets during clotting. Thus, S1P produced by platelets during clotting may play a pivotal role in attracting established endothelial cells to the injured site, an early but essential step in neovascularization and resultant wound healing.
